Cargando…
RITA1 drives the growth of bladder cancer cells by recruiting TRIM25 to facilitate the proteasomal degradation of RBPJ
Bladder cancer (BC) is one of the most prevalent malignancies worldwide, but it lacks effective targeted therapy due to its elusive molecular mechanism. Therefore, it is important to further investigate the molecular mechanisms that mediate BC progression. By performing a tumor tissue–based gene mic...
Autores principales: | Tang, Huancheng, Li, Xiangdong, Jiang, Lijuan, Liu, Zefu, Chen, Lei, Chen, Jiawei, Deng, Minhua, Zhou, Fangjian, Zheng, Xianchong, Liu, Zhuowei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9459252/ https://www.ncbi.nlm.nih.gov/pubmed/35701858 http://dx.doi.org/10.1111/cas.15459 |
Ejemplares similares
-
Knockdown of ZBTB11 impedes R‐loop elimination and increases the sensitivity to cisplatin by inhibiting DDX1 transcription in bladder cancer
por: Chen, Lei, et al.
Publicado: (2022) -
FXR1 can bind with the CFIm25/CFIm68 complex and promote the progression of urothelial carcinoma of the bladder by stabilizing TRAF1 mRNA
por: Deng, Minhua, et al.
Publicado: (2022) -
CircCA12 Promotes Malignant Process via Sponging miR-1184 and Upregulating RAS Family in Bladder Cancer
por: Jiang, Lijuan, et al.
Publicado: (2021) -
Long noncoding RNAs to predict postoperative recurrence in bladder cancer and to develop a new molecular classification system
por: Li, Zhiyong, et al.
Publicado: (2021) -
On Rita Levi-Montalcini
por: Melino, Gerry, et al.
Publicado: (2013)